Apogee Therapeutics, Inc. (APGE) has 14 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 5 sales totalling $18.4M. Most recent filing: Sept. 3, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 3, 2026 | Fairmount Funds Management LLC Director | $0 | 7,266,754 | −100% | No | |
|
|
||||||
| Sept. 3, 2026 | McKenna Mark C. Director | $0 | 202,488 | −100% | No | |
|
|
||||||
| Sept. 3, 2026 | Fox Jennifer A. Director | $0 | 67,312 | −100% | No | |
|
|
||||||
| Sept. 3, 2026 | Henderson Jane Chief Financial Officer | $0 | 542,368 | −100% | No | |
|
|
||||||
| Sept. 3, 2026 | JONES WILLIAM A JR Director | $0 | 67,312 | −100% | No | |
|
|
||||||
Showing the 5 most recent of 14 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free